Attune Neurosciences, Inc.
San Francisco, CA
- UEI
- ET2MB89ZSHH5
- CAGE
- 8GQ56
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2325 3rd St #424, San Francisco, CA 94107, USA
- Website
- attuneneuro.com
- Founded
- 2019
- Employees
- 11-50
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $1,306,972 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Research and development phase II sbir | Interior Business Center (DO) | $1,306,972 | |
| Individualized focused ultrasound stimulation for sleep on-demand (BAA number SO190122) | Medical Command (Army) | $732,435 |
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| DCS Corporation | FA865022F6466 | $166,000 |
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Semi | FA86501825402 | $496,775 |
Similar vendors
About the company
Attune Neurosciences, Inc. is a for-profit corporate entity registered in SAM.gov, specializing in developing advanced neurotechnology focused on non-invasive brain stimulation using low-intensity focused ultrasound (LIFU). The company appears to be primarily engaged in research and development of innovative medical technologies, with a particular emphasis on addressing neurological and addiction-related challenges. Their core technological approach centers on creating wearable, head-worn devices that can deliver precise ultrasound stimulation to specific brain regions to potentially treat sleep disorders, substance use disorders, and other neurological conditions.
Through federal contract awards, Attune Neurosciences, Inc. has demonstrated expertise in advanced research and development projects for defense-related agencies. The company has secured contracts from the Defense Advanced Research Projects Agency (DARPA) and the U.S. Department of the Army Medical Command, with awards totaling over $1.4 million. These contracts are primarily Small Business Innovation Research (SBIR) Phase II awards, featuring a set-aside designation for small businesses. The contract work involves sophisticated research initiatives, such as developing individualized focused ultrasound stimulation technologies for specific medical applications like sleep enhancement, with contract values ranging from approximately $689,000 to $732,000 and performance locations primarily in San Francisco, California.
In the federal grant space, Attune Neurosciences, Inc. has been awarded project grants from the National Institute on Drug Abuse (NIDA), focusing on developing non-pharmacological interventions for sleep disorders associated with substance use disorders, particularly opioid use disorder. These grants, totaling approximately $399,739, support research to create wearable, head-worn low-intensity focused ultrasound (LIFU) devices designed to improve sleep quality for individuals recovering from addiction. The grant work involves detailed research objectives, including device reconfiguration, usability studies, and developing technologies that can potentially reduce relapse rates by addressing sleep dysfunction. The grants demonstrate the company's commitment to translating advanced neurotechnology research into practical, non-invasive treatment options for complex medical challenges.
Quick answers
Is Attune Neurosciences, Inc. registered in SAM.gov?
Yes. Attune Neurosciences, Inc.'s SAM.gov registration is active through September 29, 2027.
How much has Attune Neurosciences, Inc. received in federal contracts?
Federal contracts obligated $1,306,972 to Attune Neurosciences, Inc. in fiscal year 2025.
How does Attune Neurosciences, Inc. rank among federal contractors?
Attune Neurosciences, Inc. ranked #77 in NAICS 339112 in FY2025.
What is Attune Neurosciences, Inc.'s most recent federal award?
Attune Neurosciences, Inc.'s most recent federal grant award is Head-worn low intensity focused ultrasound (lifu) device for enhancing sleep in substance use disorder (SUD) (R43DA062460), from National Institute on Drug Abuse (NIH), on January 15, 2025.
On GovTribe
See Attune Neurosciences, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors